Compounds > zm 241385
Page last updated: 2024-09-05

zm 241385 and mrs 1754

zm 241385 has been researched along with mrs 1754 in 5 studies

Compound Research Comparison

Studies
(zm 241385)		Trials
(zm 241385)		Recent Studies (post-2010)
(zm 241385)		Studies
(mrs 1754)		Trials
(mrs 1754)		Recent Studies (post-2010) (mrs 1754)
401312430013

Protein Interaction Comparison

ProteinTaxonomyzm 241385 (IC50)mrs 1754 (IC50)
Adenosine receptor A2aHomo sapiens (human)1
Adenosine receptor A2bHomo sapiens (human)0.032

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Ahern, DG; Jacobson, KA; Ji, X; Kim, YC; Linden, J1
Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E1
Azuaje, J; Brea, J; Cadavid, MI; Carbajales, C; García-Mera, X; Gutiérrez-de-Terán, H; Loza, MI; Masaguer, CF; Oliveira, A; Sotelo, E1
Alispahic, B; Åqvist, J; Azuaje, J; Brea, J; Caamaño, O; Crespo, A; El Maatougui, A; Fernandez-Masaguer, C; Freire-Garabal, M; García-Mera, X; Garcia-Santiago, C; Gioé, C; Gutiérrez-de-Terán, H; Jespers, W; Loza, MI; Majellaro, M; Mallo-Abreu, A; Novio, S; Núñez, MJ; Prieto-Díaz, R; Rodríguez-García, C; Sardina, JF; Sotelo, E; Stefanachi, A1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G1

Reviews

1 review(s) available for zm 241385 and mrs 1754

ArticleYear
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship

2022

Other Studies

4 other study(ies) available for zm 241385 and mrs 1754

ArticleYear
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
    Biochemical pharmacology, 2001, Mar-15, Volume: 61, Issue:6

    Topics: Acetamides; Cells, Cultured; Humans; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Radiopharmaceuticals; Receptor, Adenosine A2B; Tritium

2001
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
    Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5

    Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship

2016
Enantiospecific Recognition at the A
    Journal of medicinal chemistry, 2017, 04-27, Volume: 60, Issue:8

    Topics: Carbon-13 Magnetic Resonance Spectroscopy; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Receptor, Adenosine A2B; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism

2017
3,4-Dihydropyrimidin-2(1
    Journal of medicinal chemistry, 2021, 01-14, Volume: 64, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetulus; Cyclic AMP; HEK293 Cells; HeLa Cells; Humans; Models, Molecular; Neoplasm Metastasis; Pyrimidines; Radioligand Assay; Receptor, Adenosine A2B; Stereoisomerism; Structure-Activity Relationship

2021